Hispanic Patients Have Highest Survival Rate After Merkel Cell Carcinoma
Patients with MCC may have different sites of disease, stage at diagnosis, and survival outcomes according to their racial or ethnic group.
Diagnosis & Disease Information
Zynyz Approved for Metastatic or Recurrent Locally Advanced Merkel Cell Carcinoma
The FDA has granted accelerated approval to Zynyz (retifanlimab) for the treatment of adults with metastatic or recurrent locally advanced Merkel cell carcinoma.
SBRT Does Not Improve Efficacy of Nivo-Ipi in Advanced Merkel Cell Carcinoma
SBRT did not improve the efficacy of nivolumab-ipilimumab in patients with advanced Merkel cell carcinoma in a phase 2 study.
Merkel Cell Carcinoma Stage Is Strong Predictor of Recurrence Risk
Risk of stage-specific Merkel cell carcinoma (MCC) recurrence and mortality over time since diagnosis is estimated.
- Loading...
Loading...
Next post in Skin Cancer
Loading... 
Loading...